Vincristine
Drug Status in USA : Approved
Drug Status in Canada : Approved
Indication : Why is this medication prescribed?
Acute Lymphoblastic leukemia. Monhodgkins lymphoma. Hodgkins lymphoma. Wilms tumour. Lymphosarcoma. Ewings sarcoma and carcinoma lung. Immunosupressant e.g. Thormbotic thrombocytopoenic purpura. Idiopathic thrombocytopoenic purpura.
Contraindication: What are the special precautions to be followed?
Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patient
Hypersensitivity. Patients with dermyelinating form of Charcoal-Marie-Tooth syndrome. Pregnancy and lactation.Other Precaution to be observed while taking this medication
Elderly. Preexisting pulmonary dysfunction or neuromuscular disease.
What are possible side effects of this medication ?
Peripheral neuropathy, alopecia, Bone marrow depression. Hyperuricaemia, bronchospasm, azospermia, amenorrhoea, alopoecia, leucopenia, urinary dysfunction, abdominal cramps, vomiting, diarrhoea, severe constipation, paralytic ileus, convulsions, hypertension, orthostatic hypotension, ptosis hoarseness, optic neuropathies, hallucinations, blindness, difficulty in walking, syndrome of inappropriate ADH secretion.
Drug Category/Class
- Antineoplastic Agents, Phytogenic
- Tubulin Modulators
- Vinca Alkaloids and Analogues
- Immunosuppressive Agents
- Combined Inhibitors of CYP3A4 and P-glycoprotein
- Antineoplastic Agents
- Antineoplastic and Immunomodulating Agents
- CYP3A4 Inhibitors
- Vinca alkaloids and analogues
| Prescribed | Treatment of acute lymphocytic leukemia (ALL), Hodgkin lymphoma, non-Hodgkin lymphomas, Wilms' tumor, neuroblastoma, rhabdomyosarcoma. Liposomal vi... |
| Weight : | 824.9576 |
| Structure | Vincristine |
 |
| Formula | C46H56N4O10 |
Vincristine has 14 Brands listed
Search Generic Drugs alphabetically